#Abbot ID NOW

Abbot has launched a new molecular point-of-care test that can detect positive COVID-19 patients in just five minutes. Abbot's molecular test searches for just a small section of the coronavirus genome, then amplifying the said section until the virus is detected. The new test will run on Abbot's ID NOW platform. Weighing only 6.6 pounds and as large as a small toaster, Abbot's ID NOW platform can be used almost anywhere. The ID NOW COVID-19 tests had been given an Emergency Use Authorization (EUA) by the US Food and Drug Administration last Friday. It will be available in the US starting next week, and Abbot will be ramping up production to deliver 50,000 tests per day. "Through the incredible work of teams across Abbott, we expect to deliver 50,000 COVID-19 tests per day to healthcare professionals on the front lines, where testing capabilities are needed most," Chris Scoggins said, Abbot's senior vice president, Rapid Diagnostics. The Insta360 Luna Ultra is now available through authorized retailers nationwide with the following pricing: Luna Ultra Standard Bundle: PHP 46,790 Luna Ultra Creator Bundle: PHP 59,490 Alongside the launch, Insta360 Philippines announced plans to expand its retail presence nationwide, targeting 50 authorized retail locations by the end of 2026. Read more in our articles including "Abbot launches COVID-19 test that detects positive results in 5 minutes" and "Insta360 Luna Ultra launched, priced in the Philippines".